Progress toward implementation of human papillomavirus vaccination - the Americas, 2006-2010

Morbidity and Mortality Weekly Report

Volumn 60, Issue 40, 2011, Pages 1382-1384

  Vicari, Andrea S ^a   Dilsa, Lara G ^a   Deeks, Shelley ^b   Mireles, Susana P Cerón ^c   Román, Mirella Loustalot Laclette San ^c   Romero, Raquel Espinosa ^c   del Carmen Domínguez Mulato, Maria ^d   López Collada, Vesta Richardson ^d   de Moltó, Yadira ^e   de Hewitt, Itzel S ^e   Saraiya, Mona ^f   Hyde, Terri ^g   Markowitz, Lauri E ^h   Dunne, Eileen F ^h   Meites, Elissa ^h   Surie, Diya ^h  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b Surveillance and Epidemiology   (Canada)

^c National Center for Gender Equity and Reproductive Health   (United States)

^d Ministry of Health   (Mexico)

^e Ministry of Health   (Panama)

^f NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^g NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18; HUMAN PAPILLOMAVIRUS VACCINE, L1 TYPE 16, 18; WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; CHILD; FEMALE; HUMAN; IMMUNIZATION; PAPILLOMAVIRUS INFECTION; PREVENTIVE HEALTH SERVICE; UTERINE CERVIX TUMOR; VIROLOGY; WESTERN HEMISPHERE;

ADOLESCENT; AMERICAS; CHILD; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 80054801712     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Arbyn M, Castellsagué X, de Sanjosé S, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011; April 6. [Epub ahead of print].
2. de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010;11:1048-56.
3. World Health Organization. Human papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec 2009;84:118-31.
4. Gee J, Naleway A, Shui I, et al. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine 2011 (in press).
5. CDC. National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010. MMWR 2011;60:1117-23.
6. Colucci R, Hryniuk W, Savage C. HPV vaccination programs in Canada: are we hitting the mark? Report card on cancer in Canada, 2008. Toronto, Canada: Cancer Advocacy Coalition of Canada; 2008. Available at http://www.canceradvocacy.ca/reportcard/2008/HPV%20Vaccination%20Programs%20in%20Canada.pdf. Accessed October 12, 2011.
7. Public Health Agency of Canada. Publicly funded immunization programs in Canada: routine schedule for infants and children including special programs and catch-up programs (as of September 2011). Ottawa, Canada: Public Health Agency of Canada; 2011. Available at http://www.phac-aspc.gc.ca/im/ptimprog-progimpt/table-1-eng.php. Accessed October 12, 2011.
8. Pan American Health Organization. New technologies for cervical cancer prevention: from scientific evidence to program planning. Report of the Latin American Subregional Meeting on Cervical Cancer Prevention, Panama City, Panama, June 2-3, 2010.
9. LaMontagne DS, Barge S, Le NT, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ 2011; September 1. [Epub ahead of print].
10. de Oliveira LH, Danovaro-Holliday MC, Sanwogou NJ, Ruiz-Matus C, Tambini G, Andrus JK. Progress in the introduction of the rotavirus vaccine in Latin America and the Caribbean: four years of accumulated experience. Pediatr Infect Dis J 2011;30(1 Suppl):S61-6.